Home » Newsletters » BioWorld Science

BioWorld Science

July 21, 2000

View Archived Issues

Alcon to develop drop formulation of moxifloxacin

Genentech acquires rights to PSCA from UroGenesys

Genopoietic to become Avax subsidiary

GelTex receives U.S. approval for Welchol, initiates phase I study for antitoxin polymer

Idec Pharmaceuticals reports Q2 2000 results

DepoMed's Metformin GR gives positive multiple-dose phase I results

NeisVac-C meningococcal vaccine approved in U.K.

Cell Pathways and Glaxo Wellcome to study Aptosyn/Navelbine combination for NSCLC

Approval of new treatment for schizophrenia backed by FDA panel

Zambon and Sheffield submit IND for MSI-cromolyn

Boston Biomedica expands license agreement to include anti-HBV candidates

Rights to S. pneumoniae vaccine technology licensed to SB

Parecoxib at least equieffective to ketorolac in the relief of dental pain

BoNT-B demonstrates significant efficacy in pain associated with cervical dystonia

Beneficial effects described at World Congress on Heart Failure for enrasentan in SHRSP-HSHF model

Advances in gene therapy for preventing restenosis reported in Vancouver

Myocet successfully substitutes for doxorubicin in CHOP therapy of AIDS-related lymphomas

Complete inhibition of HCMV replication obtained on combination regimens

First regulatory approval obtained for Migard

Major European market launches for Enbrel

Selectin modulators and their use described in recent patent by Ontogen and Organon

Antimicrobial hygromycin A derivatives in development at Pfizer

Sumitomo describes new compounds for cardiovascular disorders

New ACAT inhibitors patented in Japan particularly useful as antiatherosclerotics

SB presents new inhibitors of a cell cycle-regulating kinase

Potassium channel-activating smooth muscle relaxants designed by AHP

AstraZeneca describes new P2T receptor antagonists useful as antithrombotics

NeoPharm seeks clearance to begin clinical development of LE-AON

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...